Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer

Peer Review reports

Original Submission
21 Jul 2020	Submitted	Original manuscript
21 Aug 2020	Reviewed	Reviewer Report
24 Aug 2020	Reviewed	Reviewer Report
22 Sep 2020	Author responded	Author comments - Hironaga Satake
Resubmission - Version 2
22 Sep 2020	Submitted	Manuscript version 2
21 Oct 2020	Author responded	Author comments - Hironaga Satake
Resubmission - Version 3
21 Oct 2020	Submitted	Manuscript version 3
Publishing
26 Oct 2020	Editorially accepted
17 Nov 2020	Article published	10.1186/s12885-020-07576-9

Back to article page